Andrew DeVivio

Andrew DeVivio is the Associate Director of Financial Evaluation & Analysis in M&A at Merck, bringing eight years of experience in finance across various roles in Corporate Finance and Investment Management. They are currently managing Merck's short-term investment portfolio and commercial paper program and are pursuing an MBA at Rutgers Business School. Andrew is a graduate of Merck’s Finance MBA Rotational Program and has held positions in R&D Finance, Commercial Finance, and Credit Research. Prior to their tenure at Merck, they worked as a Credit Analyst at RSW Investments Holdings and in various roles at RSW Investments, LLC.